Older men at risk for fractures from osteoporosis may reap the same benefit as women from bone-strengthening drugs called bisphosphonates, a new study suggests.
In this case, one such drug called zoledronic acid (Reclast) significantly reduced backbone breaks in men suffering from osteoporosis. Bisphosphonates work by building bone mass, the researchers explained.
http://www.nlm.nih.gov/medlineplus/news/fullstory_130867.html



KMF,
Wow, if they can't push them on women, now they will try for the men with OP? As far as I'm concerned, the whole bisphosphonate concept of reducing bone resorption to increase bone density is flawed. The old bone stays, and therefor decreases bone quality, ultimately resulting in fractures, the very thing these drugs were developed to prevent!
Tom